News of the index components S&P 500

Index

SP500

US78378X1072

Market Closed - USA 02:35:45 29/06/2024 am IST			5-day change	1st Jan Change
5,460 ^PTS	-0.41%		-0.08%	+14.48%

29/06	Wall St. ends lower after inflation data, debate	RE
28/06	Canadian Stocks Reverse Winning Streak	DJ

News of the index components

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Piper Sandler Upgrades Equity Residential to Overweight From Neutral, Adjusts Price Target to $80 From $70 EQR	28/06	MT
ResMed : Earnings Release Q3 2024 PDF RMD	28/06	PU
ResMed : Earnings Release Q1 2024 PDF RMD	28/06	PU
ResMed : Earnings Release FY 2023 PDF RMD	28/06	PU
ResMed : Earnings Release Q2 2022 PDF RMD	28/06	PU
ResMed : Earnings Release Q2 2021 PDF RMD	28/06	PU
The Gross Law Firm Notifies Humana Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - HUM HUM	28/06	PR
Intel Corporation Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - INTC INTC	28/06	PR
BIIB LAWSUIT ALERT: The Gross Law Firm Notifies Biogen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline BIIB	28/06	PR
Investors who lost money on UnitedHealth Group Inc.(UNH) should contact The Gross Law Firm about pending Class Action - UNH UNH	28/06	PR
ENPH LAWSUIT ALERT: The Gross Law Firm Notifies Enphase Energy, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline ENPH	28/06	PR
The Gross Law Firm Notifies Shareholders of Equinix, Inc.(EQIX) of a Class Action Lawsuit and an Upcoming Deadline EQIX	28/06	PR
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 12, 2024 in Lamb Weston Holdings, Inc. Lawsuit - LW LW	28/06	PR
Shareholders that lost money on NIKE, Inc. (NKE) Urged to Join Class Action - Contact The Gross Law Firm to Learn More NKE	28/06	PR
Goldman Sachs Adjusts Price Target on Nike to $105 From $118, Keeps Buy Rating NKE	28/06	MT
Goldman Sachs Adjusts Price Target on Nike to $105 From $118, Keeps Buy Rating NKE	28/06	MT
BMO Capital Adjusts Price Target on Nike to $100 From $118, Keeps Outperform Rating NKE	28/06	MT
Stifel Downgrades Nike to Hold From Buy, Adjusts Price Target to $88 From $117 NKE	28/06	MT
Jefferies Adjusts Price Target on Nike to $90 From $100, Maintains Hold Rating NKE	28/06	MT
Citigroup Upgrades Cincinnati Financial to Buy From Neutral, Price Target is $135 CINF	28/06	MT
BNP Paribas Exane Adjusts Price Target on Nike to $60 From $75, Maintains Underperform Rating NKE	28/06	MT
Guggenheim Adjusts Price Target on Nike to $115 From $130, Keeps Buy Rating NKE	28/06	MT
Morgan Stanley Downgrades Nike to Equalweight From Overweight, Adjusts Price Target to $79 From $114 NKE	28/06	MT
JPMorgan Upgrades Digital Realty Trust to Overweight From Neutral, Adjusts Price Target to $175 From $150 DLR	28/06	MT
Citigroup Adjusts Price Target on Nike to $102 From $115, Keeps Buy Rating NKE	28/06	MT
Carisma Therapeutics Debuts Moderna Collaboration With Solid Tumors Investigative Study; Shares Soar Premarket MRNA	28/06	MT
Evercore ISI Adjusts Price Target on Nike to $105 From $110 After Lowered Preliminary 2025 Guidance, Maintains Outperform Rating NKE	28/06	MT
Citigroup Downgrades Travelers to Sell From Neutral, Price Target is $200 TRV	28/06	MT
Citigroup Downgrades Hartford Financial Services to Neutral From Buy, Price Target is $114 HIG	28/06	MT
Truist Adjusts PT on Nike to $81 From $99 After Below-Street Fiscal Q4 Revenue, Lowered 2025 Guidance; Maintains Hold Rating NKE	28/06	MT
Evercore ISI Adjusts Price Target on Nike to $105 From $110 After Lowered Preliminary Full-Year 2025 Guidance, Maintains Outperform Rating NKE	28/06	MT
Willis Towers Watson Public : WTW publishes second annual sustainability report WTW	28/06	PU
Asian stocks, currencies nudge higher as focus turns to US inflation MSFT	28/06	RE
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares IP	28/06	AQ
Salesforce Maintains Dividend at $0.40 per Share, Payable July 25 to Shareholders of Record on July 9 CRM	28/06	MT
Biogen, Eisai Launch Leqembi in China to Treat Alzheimer's Disease BIIB	28/06	MT
AbbVie, Genmab Receive Positive European Opinion on Marketing Authorization for Possible Lymphoma Treatment ABBV	28/06	MT
Boost Tesla's Performance: Latest Upgrades and OEM Parts Now Available TSLA	28/06	AQ
Oracle Recognized as a Leader in Three Gartner Reports IT	28/06	AQ
#LifeatYUM: Meet the Director of Innovation Labs at Yum! Brands YUM	28/06	AQ